Jpmorgan Chase & CO Zomedica Corp. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ZOM
# of Institutions
95Shares Held
84.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$5.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.61MShares$1.15 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$421,1850.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$295,9830.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $118M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...